- Filed
- Mar 3, 2022 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2021 · Mar 3, 2022 | 30.06M sh |
| Capex | FY 2021 · Dec 31, 2021 | $1.82M |
| Capex | FY 2021 · Dec 31, 2020 | $3.96M |
| Shares Diluted | FY 2021 · Dec 31, 2020 | 19.09M sh |
| Operating Cash Flow | FY 2021 · Dec 31, 2020 | −$18.89M |
| Short Term Debt | FY 2021 · Dec 31, 2020 | $0 |
| Cash And Equivalents | FY 2021 · Dec 31, 2020 | $23.07M |
| Current Liabilities | FY 2021 · Dec 31, 2020 | $12.35M |
| Total Liabilities | FY 2021 · Dec 31, 2020 | $37.12M |
| Current Assets | FY 2021 · Dec 31, 2020 | $39.74M |
| Total Assets | FY 2021 · Dec 31, 2020 | $64.89M |
| Eps Diluted | FY 2021 · Dec 31, 2020 | −$1.34 |
| Eps Basic | FY 2021 · Dec 31, 2020 | −$1.34 |
| Sga Expense | FY 2021 · Dec 31, 2020 | $21.04M |
| Rd Expense | FY 2021 · Dec 31, 2020 | $9.51M |
| Net Income | FY 2021 · Dec 31, 2020 | −$25.52M |
| Operating Income | FY 2021 · Dec 31, 2020 | −$23.14M |
| Cost Of Revenue | FY 2021 · Dec 31, 2020 | $23.87M |
| Revenue | FY 2021 · Dec 31, 2020 | $32.47M |
| Stock Issued restated | FY 2021 · Apr 30, 2020 | 2.62M sh |
| Stockholders Equity | FY 2021 · Dec 31, 2019 | $24.04M |